English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

FDA announces phase-out of mandatory animal tests for monoclonal antibody drug development
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Lilly targets record revenue as competition heats up over new oral obesity drugs
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Gilead partners with OncoNano on $300 million cancer drug delivery deal
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Huntington's disease research advances despite regulatory setbacks
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Automated manufacturing seen as key solution for growing CAR T therapy demand
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Lilly partners again with Nimbus Therapeutics on preclinical oral obesity drug
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Biopharma experts call for modernization alongside expansion in US drug manufacturing
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

FDA cites safety risks and uncertain benefit in rejecting Sanofi’s MS drug

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation